SUVEN LIFE SCIENCES
Back to Balance Sheet
|
SUVEN LIFE SCIENCES Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹14 Cr | ₹105 Cr | ₹102 Cr | ₹110 Cr | ₹120 Cr |
What is the latest Total Current Liabilities ratio of SUVEN LIFE SCIENCES ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹14 Cr |
Mar2023 | ₹105 Cr |
Mar2022 | ₹102 Cr |
Mar2021 | ₹110 Cr |
Mar2020 | ₹120 Cr |
How is Total Current Liabilities of SUVEN LIFE SCIENCES Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹14 Cr | -87.13 | |
Mar2023 | ₹105 Cr | 2.75 | |
Mar2022 | ₹102 Cr | -6.92 | |
Mar2021 | ₹110 Cr | -8.52 | |
Mar2020 | ₹120 Cr | - |
Compare Total Current Liabilities of peers of SUVEN LIFE SCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUVEN LIFE SCIENCES | ₹2,622.7 Cr | -8.8% | -7.6% | 18% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹407,827.0 Cr | -3.1% | -3.9% | 12.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹157,931.0 Cr | -2.9% | -0.8% | 62.5% | Stock Analytics | |
CIPLA | ₹117,322.0 Cr | 1.1% | 0.3% | 1.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,116.0 Cr | -1.3% | -9.4% | -0.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹94,752.0 Cr | -3.7% | -5.9% | 19.7% | Stock Analytics |
SUVEN LIFE SCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUVEN LIFE SCIENCES | -8.8% |
-7.6% |
18% |
SENSEX | -2.9% |
-0.1% |
6.8% |
You may also like the below Video Courses